🏆 Deal of the Week · CW 18/2024
Vitestro raised €20M in a Series A round; the valuation remains undisclosed. The round was backed by Sonder Capital, NYBC Ventures, Inves-NL, and the European Innovation Council. The funding will support the commercialisation of Vitestro's autonomous robotic phlebotomy technology.
Vitestro — key deal facts
| Company | Vitestro |
| Founded | 2017 |
| Headquarters | Utrecht, Netherlands |
| Amount raised | ER 20M |
| Valuation | Valuation Remains Undisclosed |
| Round | Series A |
| Investors | Sonder Capital NYBC Ventures Inves-NL European Innovation Council |
| Sectors | Healthcare |
Who invested in Vitestro?
The Series A syndicate comprises Sonder Capital, NYBC Ventures, Inves-NL, and the European Innovation Council. The presence of the European Innovation Council signals institutional validation of Vitestro's deep-tech credentials, while NYBC Ventures—the venture arm of the New York Blood Center—brings strategic domain expertise in diagnostic blood services. Inves-NL adds Dutch public-sector backing, reflecting national support for medtech innovation.
What does Vitestro do?
Vitestro is a medical robotics company founded in 2017 and headquartered in Utrecht, Netherlands. It was co-founded by Brian Joseph and Toon Overbeeke, with Overbeeke serving as CEO. The company develops Aletta®, the world's first CE-marked Autonomous Robotic Phlebotomy Device™, which automates diagnostic blood collection using AI, ultrasound imaging, and robotic needle insertion. Aletta® is designed for hospitals and clinical laboratories seeking to address phlebotomist shortages and improve precision and safety in blood draws.
Vitestro valuation & multiples
No verified multiples data was provided for this deal, and Vitestro's valuation remains undisclosed, making EV/Sales and EV/EBITDA calculations unavailable at this stage. As Vitestro operates in the medical robotics segment of the broader healthcare sector, relevant benchmarks can be explored in the sector multiples pages for Healthcare and Medtech on DealMatrix.
Explore the benchmarks: Series A.
Frequently asked questions
How much did Vitestro raise in its Series A?
Vitestro raised €20M in its Series A round.
What is Vitestro's valuation?
Vitestro's valuation was not disclosed as part of this Series A financing.
Who invested in Vitestro?
The Series A was backed by Sonder Capital, NYBC Ventures, Inves-NL, and the European Innovation Council.
When was Vitestro founded and where is it based?
Vitestro was founded in 2017 and is headquartered in Utrecht, Netherlands.
Source: original announcement — read the full report.